Replies to post #337457 on NorthWest Biotherapeutics Inc (NWBO)

[jimmy667]

I have been watching developments in NWBO for a long time but did not start buying shares until you posted about it on the Anavex board. And started buying in the .60s and .70s here recently. On legal questions i don't listen to many posts as i can take my own counsel but know you practice in EU and are a credible poster.
As far as the current kerfuffle Companies fumble on disclosures negligently and intentionally so it is no assurance but I think NWBO would attempt to comply therefore I think there is a strong possibilty that NWBO will not ask for the statisticians to finalize the TLD report until the FDA has accepted the revised primary end point for the more important reason to avoid ambiguity. NWBO if they truly have a homerun will want everyone to realize the enormity of it at the first crack of the bat.
I must admit that if the trial met the revised endpoint but not the old endpoint on the US Clinical trial site then I think the NWBO can wait to release until it is finally accepted or rejected by the FDA.